Can Clinical Supply Chain Tracking Stop Trial Delays?

AdvancedUNO
5 Aug, 2026
Can Clinical Supply Chain Tracking Stop Trial Delays?

7 min read

A clinical trial coordinator at a busy metropolitan site stands before a refrigeration unit, matching a biologic vial against a handwritten log on a clipboard. This scene is not an anomaly; it is the baseline reality of modern medicine. Despite the rise of complex cell therapies and personalized biologics, clinical operations frequently depend on fragmented, manual systems that introduce quiet, systemic risk at the exact moment a patient is waiting in the clinic.

According to a industry survey by Cardinal Health, nearly one in four health systems still rely on manual processes—such as spiral-bound notebooks and spreadsheets—to manage and reorder critical medical supplies. When trials transition from standard small-molecule tablets to personalized biologics, this lack of visibility becomes a liability. The modern clinical supply chain is no longer just about moving boxes. It is about protecting the chain of custody for therapies that are manufactured in batch sizes of one, where a single temperature excursion or delivery delay can invalidate years of clinical research.

Why Clinical Supply Chains Remain Stuck in the Paper Era

We live in a hybrid state of clinical logistics. On one end, sponsors deploy sophisticated Enterprise Resource Planning (ERP) systems to plan global trials. On the other end, the physical delivery of these supplies at the clinical site remains stubbornly analogue. This disconnect is where clinical trials stall. When a shipment of investigational medicinal products (IMPs) arrives late, the clinical consequences are immediate: rescheduled infusions, compromised patient protocols, and lost data.

The scale of this issue is reflected in public healthcare data. For instance, the UK's National Audit Office reported that 26.9% of healthcare orders arrived late in 2023-24, averaging 22 days past their due date. In a clinical trial setting, a 22-day delay can end a patient's participation entirely. The waste generated by poor tracking is equally staggering. Data from the medical device sector shows that only 60% of surgical kits brought into operating rooms are actually used, representing a massive loss of capital and clinical efficiency.

The transition to digital tracking is slow because clinical sites are fundamentally overwhelmed. Site coordinators are trained in patient care, not inventory management. When a new digital tracking tool is introduced without operational integration, it is treated as administrative overhead. The coordinator, facing a waiting patient, will choose the clipboard over a complex software login every time. This is not a failure of technology; it is a failure of workflow integration.

The Operational Blueprint for Clinical Supply Chain Integration

To bridge this gap, sponsors and clinical research organizations (CROs) must implement a sequenced, site-first operational playbook. The goal is not to install more software, but to remove the friction of data entry. This requires a transition from manual logs to automated, real-time data capture across three distinct phases.

Phase 1: Establishing the Physical Scanning Baseline

The first step is replacing manual logs with barcode and RFID scanning at the point of receipt. This is where the largest immediate gains are realized. For example, Mercy Health achieved $30 million in savings by implementing a comprehensive barcode scanning program for medical device and equipment optimization. By standardizing on GS1 barcode standards, sites can scan clinical kits directly into their local inventory upon arrival, automatically updating the central trial database.

Unifying these systems is like retrofitting an old hospital with central air: you cannot simply plug in a new unit; you must open the walls and realign the existing ductwork of every department.

Phase 2: Connecting Site Inventory to Clinical Data Systems

Once physical scanning is established, the site-level inventory must be integrated directly with the trial's Interactive Response Technology (IRT) and Electronic Data Capture (EDC) systems. This prevents double-entry. When a coordinator dispenses a kit to a patient, the scan that records the dispensation must simultaneously update the clinical record and trigger an automated reorder sequence in the ERP. This step eliminates the human error inherent in manual reconciliation.

Phase 3: Integrating Specialized Courier and Cold-Chain Logistics

The final phase involves linking site inventory with specialized logistics providers. As trials increasingly use temperature-sensitive biologics and injectables, real-time tracking of temperature and location is non-negotiable. Providers like Marken, through their Laboratory Advantage service, manage this by integrating kit supply, sample return, and cold-chain monitoring into a single workflow. This ensures that when a sample is returned from a site, its temperature history is logged automatically without requiring manual data entry from the site staff.

"The integrity of a clinical sample is just as important as the integrity of the clinical data itself; if you lose track of the temperature, you lose the patient's contribution to the study."

Comparing Manual and Automated Supply Tracking Metrics

Operational Metric Legacy Manual State Automated Traceable State
Site Supply Tracking Method Spiral notebooks, spreadsheets, and sticky notes GS1-compliant barcode and RFID scanning
Surgical / Trial Kit Utilization Approximately 60% of kits used, 40% wasted Optimized inventory based on predictive demand data
Delivery Timeliness (NHS Baseline) 26.9% of orders arrive late, averaging 22 days past due Real-time tracking with proactive courier intervention
System Integration Level Siloed IT systems requiring manual double-entry Direct API integration between ERP, IRT, and EDC systems

Where Automated Tracking Breaks Down in Practice

The primary failure mode of clinical supply chain tracking is not technical; it is behavioral. If a barcode scanner is uncharged, or if the software requires a five-step authentication process, site staff will bypass it. When technology increases the time it takes to care for a patient, the technology is discarded.

In a representative phase II oncology study across twelve active sites, three temperature excursions went unreported for seventy-two hours because a site coordinator used an offline spreadsheet instead of syncing the temperature-logger data to the central portal. This is the reality of the half-finished migration. When we force sophisticated tracking tools onto clinical sites without simplifying their daily workflows, we create a false sense of security at the sponsor level while the actual site-level data remains fragmented.

The rise of decentralized clinical trials (DCTs) and direct-to-patient (DTP) delivery models increases this complexity. Delivering clinical supplies directly to a patient's home removes the clinical site as a quality control checkpoint. If the patient is responsible for logging receipt or temperature, the error rate rises. Automated tracking systems must therefore be designed with the end-user's cognitive load in mind, utilizing passive tracking technologies that require no manual input from the patient or the clinician.

The most sophisticated supply chain is only as reliable as the busiest coordinator on their worst day.

An Operator's Playbook for Implementation

  1. Audit the site-level workflow first: Before purchasing any tracking software, spend a day at three high-enrolling clinical sites. Observe how kits are received, stored, and dispensed. Identify the exact moments where coordinators revert to paper logs.
  2. Standardize on GS1 barcodes: Do not design a proprietary labeling system. Standardize on GS1-compliant barcodes that can be read by any standard scanner, reducing the hardware burden on clinical sites.
  3. Enforce system interoperability: Require your ERP, IRT, and EDC vendors to provide open APIs. Ensure that a single physical scan at the site level updates all three systems simultaneously, eliminating double-entry.

Frequently Asked Questions

What happens when a clinical trial site's local barcode scanner fails to sync with our central Interactive Response Technology (IRT) system?

When a local sync fails, the system must fall back to an offline-queued state. The scanner should store the GS1 barcode data locally with a timestamp and attempt to reconnect every 15 minutes. Site staff must be trained to check the sync status light on the hardware cradle before releasing a patient, preventing the common issue of kits being dispensed clinical-side while remaining marked "in transit" on the sponsor's dashboard.

How do we maintain temperature logs for cell and gene therapies when a shipment is delayed at an international customs border for over 48 hours?

Real-time GPS and temperature monitoring devices must be configured to ping cellular networks at regular intervals. If a customs delay occurs, the logistics team must monitor the remaining battery life of the logger and the dry ice or liquid nitrogen capacity of the shipper. The operational protocol must define a clear escalation window—typically at the 36-hour mark—to initiate re-icing procedures at the customs facility before the temperature threshold is breached.

How do we prevent site staff from bypassing automated inventory systems and reverting to spreadsheets during high-enrollment periods?

The most effective method is to make the automated system the only pathway for kit dispensation. If the IRT system will not generate a patient randomization number or dispense confirmation without a valid barcode scan of the physical kit, staff cannot bypass the system. Spreadsheets are used because they are perceived as faster; the digital workflow must be engineered to require fewer clicks than writing a line on a spreadsheet.

When integrating a new CDMO's packaging line, how do we reconcile disparate serialization standards without rebuilding our entire ERP data schema?

Rather than mapping the Contract Development and Manufacturing Organization's (CDMO) proprietary data structure directly into your core ERP, operators should utilize an GS1-compliant Electronic Product Code Information Services (EPCIS) repository as an abstraction layer. This repository acts as a translator, receiving the CDMO's serialization files, validating them against global standards, and passing clean, normalized event data to your internal SAP or clinical systems.

When you look at your current clinical trial portfolio, how many of your active sites are still tracking multi-million dollar biologic assets using a clipboard and a prayer?

Related from this blog

Sources

Next Post Previous Post
No Comment
Add Comment
comment url